The Keller Funnel:
Believing Is Achieving
SPIRAN supports innovative operative strategies to reduce the risk of breast implant bacterial contamination, helping to reduce the incidence of Capsular Contracture and potentially lower the risk of BIA-ALCL.
Evidence has been accumulating for some time that bacterial biofilm is one of the leading causes of capsular contracture. Clinical studies have shown a higher rate of bacterial recovery in patients with high-grade contracture1,2,3
Strategies to combat the development of device-associated infection form the “14 point plan” 3which recommends using an implant introduction sleeve for a no-touch introduction, to reduce skin contact and associated bacterial contamination 4,6
A published peer-reviewed study using the Keller Funnel for implant introduction showed bacterial contamination from breast parenchyma was two-times more likely than with the standard digital insertion technique. The Keller Funnel was shown to significantly reduce the amount of skin contact by 27-fold and thus potential implant contamination .5
The use of the Keller funnel, distributed by Spiran in Australia, has the potential to significantly reduce bacterial biofilm contamination on the breast implant and thus reduces the risk of capsular contracture.